US Stock MarketDetailed Quotes

KURA Kura Oncology

Watchlist
  • 7.780
  • -0.390-4.77%
Close Jan 8 16:00 ET
  • 7.750
  • -0.030-0.39%
Post 18:44 ET
605.00MMarket Cap-3.31P/E (TTM)

Kura Oncology Key Stats

Kura Oncology Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-0.63
-0.63
-<0.01
Miss Est.
-25.21%
-26.00%
-0.66%
Net Income
--
-54.40M
--
-40.94%
Strong Buy

Jan 8, 2025

Kura Oncology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 0.000 --
-- 2024/Q4 -- / 57.962M --
Nov 7, 2024 2024/Q3 0.000 / 0.000 --
Aug 8, 2024 2024/Q2 0.000 / 0.000 --
May 2, 2024 2024/Q1 0.000 / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 57.962M--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 2, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Kura Oncology Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 8, 2025

Strong Buy

  • Buy

    87.50%
  • Hold

    12.50%
  • Sell

    0.00%

Price Target

No Data